Rainbow Rare Earths Phalaborwa project shaping up to be one of the lowest cost producers globally. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAngle Regulatory News (AGL)

Share Price Information for Angle (AGL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 14.25
Bid: 14.00
Ask: 14.50
Change: 0.00 (0.00%)
Spread: 0.50 (3.571%)
Open: 14.25
High: 14.25
Low: 14.25
Prev. Close: 14.25
AGL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

New Venture Company

17 May 2006 07:00

Angle PLC17 May 2006 For Immediate Release 17 May 2006 ANGLE plc ('ANGLE' or 'the Company') New Venture Company: Kaloptics, Inc. ANGLE plc ('ANGLE'), the venture management and consulting company specialising in the commercialisation of technology, is pleased to announce that it has signed an agreement with New York University (NYU) to commercialise innovative technology developed at the Media Research Lab in the Computer Science Department of NYU's Courant Institute of Mathematical Sciences. The agreement was effective on 30 April but for reasons of commercial confidentiality was embargoed until now. Researchers Ken Perlin, PhD and Jeff Han have developed a patent-pendingkaleidoscope and software system that enables the rapid capture and recreationof photo-realistic surface images. The technology has a wide range of commercialapplications in multi-billion dollar industries, including special effects,animation, computer gaming and medical devices. As part of its normal model for venture creation, ANGLE has formed and willincubate Kaloptics, Inc. to lead the technology commercialisation, market and IPassessment, and business strategy. ANGLE will contribute the initial managementof Kaloptics and lead a seed financing round for the company. Ken Perlin is a professor in the Department of Computer Science at NYU and wasfounding director of its Media Research Lab. His research interests includegraphics, animation, user interfaces and multimedia. He also received an AcademyAward for Technical Achievement from the Academy of Motion Picture Arts andSciences. Jeff Han, a computer science researcher at NYU, has been working in the fieldsof real-time computer graphics, computer vision, human-computer interfaces andmachine learning for over ten years. ANGLE's Chief Executive, Andrew Newland, said: "We are delighted to be working with New York University and its Media ResearchLab. These are world-class researchers who have produced numerous contributionsto their fields. We believe that the Kaleidoscope system can address a majorissue in multiple markets - the cost effective acquisition of data that can beused for the creation of realistic surface images." For further information ANGLE plc +44 1483 295830Andrew Newland, Chief ExecutiveRob Kornblum, Managing Director US Ventures Buchanan Communications +44 20 7466 5000Richard Darby, Suzanne Brocks, James Strong, Amy Rajendran Note to editors: About ANGLE Founded in 1994, ANGLE is an international venture management and consultingcompany focusing on the commercialisation of technology and the development oftechnology-based industry. ANGLE creates, develops and advises technologybusinesses on its own behalf and for its clients. ANGLE operates from offices inthe UK, the US and the Middle East. ANGLE is listed on AIM (AGL.L); further information can be found atwww.angleplc.com About NYU New York University, located in the heart of Greenwich Village, was establishedin 1831 and is one of America's leading research universities and a member ofthe selective Association of American Universities. It is one of the largestprivate universities, it is a leader in attracting international students andscholars in the U.S, and it sends more students to study abroad than any otherU.S. college or university. Through its 14 schools and colleges, NYU conductsresearch and provides education in the arts and sciences, law, medicine,business, dentistry, education, nursing, the cinematic and performing arts,music, public administration, social work, and continuing and professionalstudies, among other areas. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
27th Jan 201610:42 amRNSNotice of Interim Results
25th Jan 20167:00 amRNSUKE publishes evaluation of Parsortix
22nd Dec 20157:00 amRNSCompletion of Geomerics Transaction
15th Dec 20157:00 amRNSParsortix first commercial sales
10th Dec 20157:00 amRNSChange of FTSE Industry Classification Benchmark
30th Nov 20155:56 pmRNSHolding(s) in Company
17th Nov 20157:00 amRNSLung Cancer Research Publication
12th Nov 20152:17 pmRNSISSUE OF SHARE OPTIONS
14th Oct 20157:00 amRNSPatent Grant
30th Sep 20155:50 pmRNSResult of AGM
28th Sep 20157:00 amRNSOvarian cancer results
24th Sep 20157:00 amRNSProstrate cancer study published PLOS ONE Journal
9th Sep 20157:00 amRNSBREAST CANCER RESULTS PRESENTED AT CDX CONFERENCE
8th Sep 20153:54 pmRNSAnnual Report and Accounts and Notice of AGM
26th Aug 20151:48 pmRNSIssue of Equity and Total Voting Rights
23rd Jul 20157:00 amRNSFinal Results
20th Jul 20157:00 amRNSNotification of Preliminary Results
8th Jul 20157:00 amRNSAppointment Of Scientific Adviser
11th Jun 20157:00 amRNSBarts Prostate Cancer Update
3rd Jun 20157:00 amRNSAppointment of Scientific Adviser
26th May 20157:01 amRNSNew Patent Grants
21st Apr 20157:00 amRNSOvarian Cancer Update
20th Apr 20157:00 amRNSSidney Kimmel Cancer Centre
14th Apr 20157:00 amRNSIssue of Equity
4th Mar 20157:00 amRNSOffer to Shareholders
25th Feb 20151:11 pmRNSIssue of Equity
20th Feb 20154:05 pmRNSHolding(s) in Company
16th Feb 20157:01 amRNSMD Anderson Collaboration
16th Feb 20157:00 amRNSPlacing, Subscription and Offer
29th Jan 20157:00 amRNSInterim Results
27th Jan 20157:01 amRNS"Unprecedented Specificity" in Ovarian Cancer
23rd Jan 20157:00 amRNSCorporate Collaboration
23rd Jan 20157:00 amRNSPointMan collaboration with ANGLE plc
21st Jan 20153:00 pmRNSFurther information re Director's share transfer
19th Jan 20157:00 amRNSNotification of Interim Results
8th Jan 20157:00 amRNSCorporate Collaboration
15th Dec 20147:00 amRNSCancer Research Manchester Institute Publication
12th Nov 20147:00 amRNSFurther information re Director's share transfer
10th Nov 20147:00 amRNSIssue of Share Options
31st Oct 20147:00 amRNSADR PROGRAMME
21st Oct 20147:00 amRNSDirector's Share Transfer
17th Oct 20147:00 amRNSCollaboration with Barts Cancer Institute
17th Oct 20147:00 amRNSKey Opinion Leaders Report on Parsortix System
30th Sep 20144:30 pmRNSResult of AGM
30th Sep 20147:00 amRNSCollaboration with Thomas Jefferson University
25th Sep 20147:00 amRNSADR Programme, FDA Update and US Appointment
19th Sep 20147:00 amRNSBreast Cancer Collaboration
17th Sep 20147:00 amRNSCollaboration with Medical University of Vienna
8th Sep 20147:00 amRNSHamburg-Eppendorf Collaboration
4th Aug 20147:00 amRNSParsortix Granted Second US Patent

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.